Keywords: NAME; Cancer; Haem iron; Nitrite/nitrate/N-nitroso compounds; PAH; HCA; Epidemiology; ADI; Acceptable Daily Intake; BAC; Bacon; BUR; Beef burger; BLOOD; Blood pudding; EFSA; The European Food Safety Authority; FILET; Pork filet; HAM; Dried ham; HCA; Heterocycli
مقالات ISI NAME (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: NAME; ADI; Tempering process; Hardness measurement; Phase transformation; Microstructure;
Keywords: NAME; ASD; Autism spectrum disorder; R. Time; Retention time; DSM-5; Diagnostic and Statistical Manual of Mental Disorders, fifth edition; DISCO; Diagnostic Interview for Social and Communication Disorders; ADI; Autism Diagnostic Interview; ADOS; Autism Diagnos
Keywords: NAME; ADI; austempering; graphite nodules; phase transformation; RSM;
Keywords: NAME; Taste; Sweet; Diet; Pregnancy; Sucrose; Sucralose; FDA; Food and Drug Administration; USA; United States of America; ADI; Acceptable Daily Intake; ace-K; acesulfame-K; T1R2; (taste 1 receptor 2); T1R3; (taste 1 receptor 3); HED; human equivalent dose; NHA
Keywords: NAME; ADC; arginine decarboxylase; ADI; arginine deiminase; ADI-PEG20; ADI- polyethylene glycol 20; AIF; apoptosis-inducing factor; AMPK; AMP-activated protein kinase; Arg; arginine; ASL; argininosuccinate lyase; Asn; asparagine; ASS1; argininosuccinate synthas
Keywords: NAME; PCA; Principle component analysis; CA; Cluster analysis; MLR; Multivariate linear regression; P; Partition index; THQ; Total hazard quotient; HQ; Hazard quotient; Riski; Carcinogenic risk posed by single heavy metal; RiskTotal; Total carcinogenic risk pos
Keywords: NAME; TFNG; N-(4-trifluoromethylnicotinoyl) glycine; TFNA-AM; 4-trifluoromethylnicotinamide; TFNA; 4-trifluoromethylnicotinic acid; LODs; limits of detection; LOQs; limits of quantification; RSDs; relative standard deviations; MRLs; maximum residue levels; ADI;
Keywords: NAME; ADI; acceptable daily intake; BMI; body mass index; BW; body weight; BP; bisphenol; BP-3; oxybenzone/benzophenone-3; BuP; butyl paraben; DEMOCOPHES; Demonstration of a study to Coordinate and Perform Human biomonitoring on a European Scale; EDCs; endocrin
Keywords: NAME; ADI; Acceptable Daily Intake; BMD; Benchmark dose; BQ; Benchmark Quotient; CMR; carcinogenic, mutagenic, or toxic to reproduction; CEC; contaminants of emerging concern; DNEL; Derived No Effect Level; GLV; guideline value; LO(A)EL; Lowest Observed (Advers
Keywords: NAME; β-HCH; β-hexachlorocyclohexane; µg/l; microgram per liter; µM/l; micromolar per liter; Ʃ; total; 1-HP; 1-hydroxypyrene; 2; 3-DHBA, 2,3-dihydroxybenzoic Acid; 2cx-MMHP; mono-(2-carboxymethylhexyl) phthalate; 3PBA; 3-phenoxybenzoic acid; 4F3PBA; 4-fluo
Keywords: NAME; Automatic; Change detection; Fuzzy measurement; Remote sensing; ADI; absolute difference image; ANN; artificial neural networks; BCM; binary change map; CD; change detection; DI; difference image; DN; digital number; FPOC; fuzzy possibility of change; LC;
Keywords: NAME; Risk prioritization; FCM; Structure assessment; Semi-quantification; Exposure assessment; Hazard assessment; ADI; applicability domain index; CMR; carcinogenicity, mutagenicity, reproductive toxicity; EDA; effect directed analysis; FCM; food contact mater
Keywords: NAME; DM; diabetes mellitus; BW; body weight; ADI; acceptable daily intake; OGTT; oral glucose tolerance test; SC; subcutaneous; IP; intraperitoneal; SD; standard deviation; Diabetes mellitus; Stevioside; Stevia rebaudiana;
Keywords: NAME; Human lactation; Deuterium dilution; Organochlorine; Pyrethroid; AA; agricultural area; ADI; acceptable daily intake; D2O; deuterium oxide; DDE; dichlorodiphenyldichloroethylene; DDT; Dichlorodiphenyltrichloroethane; EBF; exclusive breastfeeding; FFM; fat
Keywords: NAME; ADI; acceptable daily intake; BMI; body mass index; CI; confidence interval; DF; detection frequency; DAPs; dialkyl phosphates; DEDTP; diethyl dithiophosphate; DEP; diethyl phosphate; DETP; diethyl thiophosphate; DMDTP; dimethyl dithiophosphate; DMP; dime
Keywords: NAME; Daily intake; EDI; ADI; Safety margin metrics; Food; Organophosphorus pesticides; Peaches; Risk assessment; Risk characterization; Risk-informed decision-making;
Keywords: NAME; ADI; acceptable daily intake; bw; body weight; CCα; limit of decision; CCβ; detection capability; DNC; 4-4-dinitrocarbanilide; EFSA; European Food Safety Authority; ELISA; enzyme-linked immunosorbent assays; ESI; electrospray ionization; FCIAS; flow cyt
Keywords: NAME; ABTS; 2,2â²-azino-di-[3-ethylbenzthiazoline sulphonate]; ADI; acceptable daily intake; BHT; butylated hydroxytoluene; DCFH-DA; 2â²,7â²-dichlorofluorescein diacetate; DPPH; 1,1-diphenyl-2-picrylhydrazyl; DY; dough yield; FBS; fetal bovine serum; GRAS; g
Keywords: NAME; Rare earth elements; ADI; Yttrium; Subchronic toxicity; NOAEL;
Keywords: NAME; ASD; autism spectrum disorder; fMRI; functional magnetic resonance imaging; ASD-EXP; children with ASD in the treatment group; ASD-WLC; children with ASD in the waitlist control group; LIOG; left inferior occipital gyrus; LFFG; left fusiform gyrus; LSTG;
Keywords: NAME; Dietary exposure; Intense sweeteners; Food label survey; Occurrence; Consumers in Italy; ADI; Acceptable Daily Intake; bw; body weight; EFSA; European Food Safety Authority; FFT; Food For Thought - The International Food and Drink Markets Consultancy; ML(
Keywords: NAME; Nickel; Toxicity reference value; RfD; ADI; Nickel sensitization; Developmental toxicity; Child; ADI; Acceptable Daily Intake; AIC; Akaike Information Criterion; ATSDR; Agency for Toxic Substances and Disease Registry; AUC; area under the plasma concentra
Keywords: NAME; Computed tomography; image processing; severe asthma; air trapping; image registration; luminal narrowing; wall thickening; airway circularity; cluster analysis; neutrophilic asthma; ACQ; Asthma Control Questionnaire; ACT; Asthma Control Test; ADI; Anisot
Keywords: NAME; AA; amino acid/amino acids; AAD; amino acid detection; ADI; arginine deiminase; ADT; arginine deprivation therapy; ALL; acute lymphoblastic leucemia; APCI; atmospheric pressure chemical ionization; APPI; atmospheric pressure photo ionization; AQC; aminoqu
Keywords: NAME; Arginine-catabolizing enzymes; Cellular metabolism; Combination therapy; Patient-derived GBM cell lines; Radiation; ADI; arginine deiminase; Arg; l-Arginine; ArgI; Arginase I; ASL; argininosuccinate lyase; ASS1; argininosuccinate synthetase 1; CPSI; Carba
Keywords: NAME; ADI; autism diagnostic interview; ADOS; autism diagnostic observation schedule; AIN; Action Imitation network; AQ; autism-spectrum quotient; ART; Artifact Detection Tools; ASD; autism spectrum disorder; EBA; extrastriate body area; EEG; electroencephalogr
Keywords: NAME; ADI; acceptable daily intake; AUC; area under the curve of blood concentration vs. time; DLS; dynamic light scattering; DMEM; Dulbecco's modified Eagle's medium; DMSO; dimethyl sulfoxide; DSC; differential scanning calorimetry; GI; gastrointestinal; IEC6
Keywords: NAME; AAS; Atomic Absorption Spectrometry; ADI; Acceptable daily intake; AMAN; Aliansi Masyarakat Adat Nusantara (Indigenous Peoples of the Archipelago Alliance); ASGM; Artisanal small-scale gold mining; CGGM; Community Green Gold Mining; CI; Confidence interva
Keywords: NAME; AChE; acetylcholinesterase; ADI; acceptable daily intake; ALAT; alanine aminotransferase; ASAT; aspartate aminotransferase; BChE; butyrylcholinesterase; CPF; chlorpyrifos; ED; endocrine disruptor; E2; estradiol; ERα; estrogen receptor alpha; FSH; follicl
Keywords: NAME; 6ACM; 6-acetylmorphine; ADI; acceptable daily intake; ALP; alprazolam; AM; amphetamine; ATC; Anatomical Therapeutic Classification; ATS; amphetamine-type stimulant; BE; benzoylecgonine; BQ; benchmark quotient; BW; body weight; CAF; caffeine; CBD; cannabid
Keywords: NAME; Glyphosate; Pesticide; Dietary exposure; Deterministic risk assessment; Probabilistic modelling; Chronic consumption; ADI; acceptable daily intake; AMPA; aminomethyl-phosphonic acid; BfR; Federal Institute for Risk Assessment; CF; conversion factor; CFR;
Keywords: NAME; CVD; Chemical Vapor Deposition; ADI; Austempered ductile iron; HRC; Rockwell hardness measured on “C” scale; Austempered ductile iron; Surface roughness; Taguchi; Tool wear;
Keywords: NAME; Subdiffusion; Fractional linear multistep method; ADI; Fast Poisson solver; Compact finite difference; Unconditional stability; Convergence;
Keywords: NAME; ADI; Alternating Direction Implicit; NFD; Number of Finite Differences; CFD; Computational Fluid Dynamics; ODE; Ordinary Differential Equation; FDM; Finite Difference Method; PSM; Power Series Method; NDF; Numerical Differentiation Formula; SLP; Sturm-L
Keywords: NAME; Atlantoaxial dislocation; C1-C2 joint orientation; Multiple planes; Multiplanar realignment; Newer indices; AAD; Atlantoaxial dislocation; ADI; Atlantodental interval; AP; Anteroposterior; BI; Basilar invagination; C1; Atlas vertebra; C2; Axis; CT; Comput
Keywords: NAME; Fractional Allen-Cahn equation; Sharp interface; Eulerian method; ADI; Spectral method; Variable fractional order;
Keywords: NAME; Rebaudiosides; Steviol glycosides; In vitro metabolism; Anaerobic; Human; Safety; Stevia leaf extract; ADI; acceptable daily intake; bw; body weight; CAC; Codex Alimentarius Commission; ESI; electrospray ionization; FDA; U.S. Food and Drug Administration
Keywords: NAME; ADI; acceptable daily intake; Apaf-1; apoptotic protease activating factor-1; ATF4; activating transcription factor 4; CHOP; C/EBP-homologous protein; eIF2α; eukaryotic initiation factor 2 alpha; ER; endoplasmic reticulum; G; ghrelin; GH; growth hormone;
Keywords: NAME; ADI; Average daily intake; BCF; Bioconcentration factor; CDF; Cumulative distribution function; CR; Cancer risk; CTE; Central tendency exposure; HQ; Hazard quotient; RfD; Toxicological reference dose; RME; Reasonable maximum exposure; SF; Cancer slope fac
Keywords: NAME; ADI; acceptable daily intake; AFB1; aflatoxin B1; AFB2; aflatoxin B2; AFG1; aflatoxin G1; AFG2; aflatoxin G2; AF; sum of aflatoxins B1Â +Â B2Â +Â G1Â +Â G2; BMD; benchmark dose; BMDL; BMD lower limit; DALY; disability-adjusted life year; DON; deoxynivalen
Keywords: NAME; Autism spectrum disorder; Cerebellum; Voxel based morphometry; SUIT; ADOS; ADI
Keywords: NAME; ADI; austempered ductile iron; CEV; carbon equivalent value; CMM; coordinate measuring machine; Mg; geometric modulus; LGI; Lamellar graphite iron; MP; measurement position; MEF; modulus extension factor; PPI; pores per inch; SGI; spheroidal graphite iron
Keywords: NAME; advanced therapy medicinal product; advanced therapy medicinal product with hospital exemption; genetically modified organism; market access; ADI; aid for development of innovation; AFM; French Association against Myopathies (Association Française contre
Keywords: NAME; Dietary exposure assessments; Uncertainty analysis; Tiered approach; Deterministic models; Point estimates; Probabilistic models; ADI; acceptable daily intake; APET; Added Portions Exposure Technique; EFCOVAL; European Food Consumption Validation; EFSA; E
Keywords: NAME; ACSS; acetyl-CoA synthetase; ADI; arginine deiminase; AML; acute myeloid leukaemia; AMPK; AMP-activated protein kinase; ALL; acute lymphoblastic leukaemia; ASS; argininosuccinate synthase; BCAAs; branched-chain amino acids; BPTES; bis-2-(5-phenylacetamido
Keywords: NAME; Risk-based; Pesticide residues; Monitoring; Sampling plan; Fresh produce; ADI; Acceptable Daily Intake; MRL; Maximum Residue Level; RASFF; Rapid Alert System for Food and Feed; ThMDI; Theoretical Maximum Daily Intake; QMS; Quality management systems;
Keywords: NAME; ADI; acceptable daily intakes; MS; metabolic syndrome; NNS; non-nutritive sweeteners; T1R; taste receptors type 1; T1R1; taste receptors type 1 subunit 1; T1R3; taste receptors type 1 subunit 3; Non-nutritive sweeteners; Pregnancy; Fetal programming; Meta
Keywords: NAME; ADI; acceptable daily intake; ANOVA; analysis of variance; CCα; decision limit; CCβ; detection capability; CV; covariance; DMSO; dimethyl sulfoxide; E2; 17β-estradiol; EC50; concentration yielding 50% increase in maximal response; ED; endocrine disrupt
Keywords: NAME; ADI; Acceptable Daily Intake; D; Decimal (1/10) homeopathic potency, Decimal Hahnemannian dilution; FSD; First Safe Dilution; GHP; German Homeopathic Pharmacopoeia; HMA; Heads of Medicines Agencies; HMPWG; Homeopathic Medicinal Products Working Group of H